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ABSTRACT  Cerebroside  sulfotransferase  (CST) catalyzes  the  final  step  in  the  synthesis  of 
sulfatide  (sulfogalactocerebroside)  by transferring the sulfate  from  3'-phosphoadenosine  5'- 
phosphosulfate  (PAPS) to  galactocerebroside.  Orientation  of  CST  was  studied  in  vesicles 
enriched in this enzyme obtained from 21-d-old rat brain. Several  lines of evidence  indicate 
that  CST  is  located  on  the  luminal  side  of  these  vesicles.  (a)  Sulfation  of  endogenous 
galactocerebroside  occurred  in  vesicles  only  in  the  presence  of a detergent  to  render the 
membranes  permeable to exogenous  PAPS. (b) There is a pool of latent enzyme within the 
vesicle,  which  is  released  by Triton  X-100.  (c) CST  is  not  destroyed  by trypsin  unless  the 
vesicle  membranes are first made permeable by Triton X-100.  (d) Glycolipid  substrate,  when 
covalently  attached  to agarose  beads,  was not sulfated  unless  the enzyme was solubilized. 
These  results  are similar to those obtained  with thiamine  pyrophosphatase,  which  is known 
to be located within the lumen of the vesicles. 
This study establishes  that an enzyme synthesizing a complex glycolipid  is localized within 
Golgi-enriched  vesicles.  Since the product of the CST reaction  must also be localized  to the 
luminal  side  of the vesicles,  it  is most  likely that sulfatide  is  located  at the  intraperiod  line 
(outer layer)  of myelin. The orientation  of CST within the vesicle  provides  a mechanism  for 
the asymmetrical assembly of glycolipids in bilayers. 
Sulfatide (galactocerebroside 3-sulfate) is a  major glycolipid 
of the  myelin  sheath  (1).  Although  clearly  an  important 
component, its function in this membrane is uncertain. Based 
on its ionic interaction with myelin basic protein in vitro, it 
has  been  implicated  as  playing a  role  in  maintaining  the 
integrity of myelin (2-5). Recent studies by Omlin et al. (6) 
have confirmed the original studies of Herndon et al. (7) that 
myelin basic  protein  is  located  at the  cytoplasmic surface 
(major dense line) of myelin. From this it might be inferred 
that sulfatide, if it interacts with myelin basic protein, would 
have a  similar location.  However, among other postulated 
roles for sulfatide are that it is part of the Na+/K+ ATPase 
molecule, where it is involved in transport (8), and that it acts 
as  a  receptor  for  opiates  (9-11).  These  properties  would 
require sulfatide to be on the external surface of the plasma 
membrane.  Immunocytochemical  studies  with  antibodies 
against both sulfatide and its synthetic enzyme, cerebroside 
sulfotransferase (CST) ~, located these to the brush border of 
renal tubules (12,  13). A clearer knowledge of the location of 
Abbreviations used in this paper:  CST, cerebroside sulfotransfer- 
ase; PAPS, 3'-phosphoadenosine 5 '-phosphosulfate. 
sulfatide in the membrane would aid in determining its bio- 
logical role. 
Sulfatide is an anionic glycolipid that in biological mem- 
branes contains tightly bound water molecules (14), and there- 
fore it  is  unlikely that  it could  readily undergo  "flip-flop" 
movement in the lipid bilayer (l 5,  16). Thus sulfatide should 
be found in the same location as the enzyme catalyzing the 
final step in its synthesis. This step, the sulfation of cerebro- 
side, is catalyzed by the enzyme galactocerebroside sulfotrans- 
ferase (EC 2.8.2. l 1), which is found in the Golgi-rich fraction 
of  both kidney and central nervous system (17-19). In vesicles 
prepared from the Golgi apparatus from the liver and kidney, 
enzymes involved in  the  synthesis  of "complex" carbohy- 
drates have been shown to be oriented towards the luminal 
(cisternal) side of the vesicles,  while other enzymes such as 
5'-nucleotidase, fatty acid-CoA ligase,  glycerol 3-phosphate 
acyltransferase, and lysophosphatidic acid acyltransferase are 
located on the cytoplasmic side of the vesicles (20-23). 
In this communication, we describe the use of  the strategies 
employed  for  the  analysis  of the  orientation  of enzymes 
involved  in  the  formation  of phospholipids  and  complex 
carbohydrates (20,  22,  23),  to show that CST is localized on 
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"markers." This suggests that the product sulfatide will also 
be on the luminal side of the Golgi apparatus and thus it is 
most likely to be located on the outer half (intraperiod line) 
of the myelin lipid bilayer. 
MATERIALS  AND  METHODS 
Materials 
Sprague-Dawley rats  (Charles  River  Farms,  Boston,  MA) were obtained 
between  l0  and  15  d  postnatal.  Phosphoadenosine  phospho[aSS]sulfate was 
obtained  from New England  Nuclear  (Boston,  MA); galactocerebroside was 
obtained from Supelco, Inc. (Bellefonte, PA), and 2-N-morpholinoethane  sul- 
fonic acid, Trizma base, glycine, acetyltrypsin, trypsin, citric acid, and ammo- 
nium molybdate  were obtained  from Sigma Chemical  Co. (St. Louis, MO). 
Thiamine  pyrophosphate  was obtained  from Calbiochem-Behring Corp. (San 
Diego, CA) and recrystallized from acetone/methanol.  Sucrose was obtained 
from Fisher Scientific Co. (Fair Lawn, N  J). All solvents were reagent grade. 
Preparation of Vesicle Fraction from Rat Central 
Nervous System 
Forebrains from 5-10 rats of about 21 d of  age were removed, washed, and 
then minced at 4°C with the use of a razor. This tissue was then homogenized 
in 4 volumes  of 0.32  M  sucrose and the homogenate  was centrifuged in a 
Sorvall RC  2B (DuPont lnstruments-Sorvall  Biomedical  Div.,  Wilmington, 
DE) at 8OO g for 10 min at 4°C. The supernatant  fraction was saved and the 
pellet was rehomogenized in 4 volumes of  0.32 M sucrose and recentrifuged at 
8OO g for an additional  l0 rain. The supernatant fractions from both centrifu- 
gations were combined, and recentrifuged in a Sorvall RC 2B at 6,000 g for 20 
min. The resulting supernatant fraction was placed in a polyallomer tube (l x 
31/2 inches) containing  a 6.0-ml cushion  of 1.6 M sucrose. These tubes were 
centrifuged  for 60  min at  100,OO0 g  in a  Beckman  ultracentrifuge  LS  2B 
(Beckman Instruments,  Inc. Spinco Div., Palo Alto, CA). The material at the 
interface was collected and used for the subsequent studies (vesicle preparation). 
Preparation of the Vesicles for 
Electron Microscopy (24) 
The  subeellular  fraction  was  collected  by  centrifngation  in  a  Beckman 
microfuge B and resuspended in a cold solution of 1% paraformaldehyde and 
1.25% glutataldehyde in phosphate buffer. After fixation for 24 h at 4°C, the 
fractions were sedimented  by centrifugation,  postfixed in osmium tetroxide, 
dehydrated  in  graded  ethanol  solutions,  cleared  with  propylene  oxide, and 
infiltrated with epoxy resin. Thin sections were stained by flotation on uranyl 
acetate and lead citrate solutions and examined with a Hitachi 600+1 electron- 
microscope. 
Assay for Cerebroside Sulfotransferase (CST) (13) 
The incubation  mixture contained  the following components in a volume 
of IOO ~tl: 100 mM 2[N-morpholino]ethane  sulfonic acid (pH 6.2), 20 mM 
MgCI2, 4 mM dithiothreitol,  2.5  mM ATP,  2.6  x  l0  s dpm of [abS]3'-phos- 
phoadenosine  5'-phosphosulfate  (PAPS) (I.0-2.8 mCi/mmol), 8 ~1 of galacto- 
cerebroside (final concentration,  80 #M),  and 40  gl of enzyme  preparation 
(containing 1OO-150 gg of  protein). The mixture was incubated at 37°C for the 
times specified. The reaction was stopped by addition of  chloroform/methanol, 
1:1  (vol/vol) followed by lipid extraction (11, 25), and the radioactivity in the 
sulfatide was determined. 
Assay for Thiamine Pyrophosphatase 
The vesicle fraction was mixed with 20 mM Tris-HCl  (pH 8.0) and  I 1% 
sucrose (final concentration).  The thiamine pyrophosphatasc  (TPPase) assay 
was conducted  as described  by Allen  and  Slater  (26, 27). The incubation 
mixture contained  33 mM sodium barbital (pH 9.5), 15 mM calcium chloride, 
and 3.3 mM recrystallized thiamine  pyrophosphate.  The reaction was started 
by the addition of 100 ~l of the fraction to be analyzed (containing 0.2-0.8  mg 
of protein), and the mixtures were incubated at 37°C for 5, 10, 15, 20, 45, and 
60 min. The reaction was stopped by the addition of trichloroacetie acid (final 
concentration  5% wt/vol). The protein  was centrifuged at 3,000 rpm for 15 
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rain at 4"C in a Sorvall RC 2B and phosphate  was determined in the supernatant 
fraction, as described below. 
Phosphate was measured  as described by Heinonen  and Lahti (28). Stock 
solutions of l0 mM ammonium molybdate,  1 M citric acid, and 5. N sulfuric 
acid were prepared. Before each assay a fresh mixture of  acid-acetone-molybdate 
was made (acetone/sulfuric  acid/ammonium molybdate 2:1:1 [vol/vol]). The 
assay mixture contained 0.5 ml of the sample,  100 #l of 10% sodium dodecyl 
sulfate, 4.0 ml of acid-acetone-molybdate  mixture,  and 0.4  ml of 1 M citric 
acid that was added  last to complex with unreacted  molybdate.  The mixture 
was treated with a Vortex mixer for  15 s and the optical density was read at 
355 nm. The standard  curve for the phosphate  determinations  was obtained 
with  monobasic  potassium  phosphate  (phosphate  concentrations  from 20- 
1,500 nmol of inorganic phosphate). 
Sulfation of Calactosylsphingosine Linked to 
Agarose Beads 
To prepare the derivatized beads, Affi-Gel l0 (Bio-Rad Laboratories, Rich- 
mond, CA) was washed four times with 4 volumes of cold isopropanol (4°C) 
followed by three washings with 3 volumes of dimethyl sulfoxide (DMSO). To 
this  resin was added  25  mg of galactosylsphingosine (Sigma Chemical  Co.) 
containing  3-6  x  l0  s clam of [aH]galactosylsphingosine (kindly provided  by 
Dr. Yasuo Kishimoto, Kennedy Institute, Johns Hopkins School of Medicine) 
dissolved in 4.0 ml of DMSO. This mixture was stirred gently for 16-20 h at 
room temperature.  The resin was washed three times with 3 volumes of  DMSO. 
Subsequently, the resin was incubated with 2 volumes of 1.0 M 2-aminocthanol, 
pH 8.0, in water for 4 h at room temperature  to block any remaining active 
sites. The resin was then washed extensively with 0.05 M sodium phosphate 
buffer, pH 7.0, containing  0.5 M NaCl. Based on the amount of [3H]galaeto- 
sylsphingosine remaining, the amount bound to the resin was 10-14 zmol/ml 
of resin. 
For the sulfation studies, the glycolipid-coupled resin was first equilibrated 
in  100  mM 2-N-morpholinoethane  sulfonic acid buffer, pH 6.2, containing 
0.32  M  sucrose,  80  mM  MgCI2, 2  mM  mereaptoethanol,  and  0.25 mM 
galactose. To this resin were added  100 #1 of incubation  buffer, 4 #l of [3sS  l- 
PAPS, and  100 ~1 of an intact  vesicle preparation  or solubilized enzyme, and 
the  mixtures  were incubated  for  10,  15,  20,  and 45  min.  The beads  were 
removed  by  centrifugation,  washed, and the  radioactivity  incorporated  was 
determined by standard procedures. 
Orientation of Thiamine Pyrophosphatase and 
CST in Isolated Vesicles 
Thiamine Pyrophosphatase:  The thiamine pyrophosphatase assay 
described above  was carried  out in the  presence of the  nonionic  detergent 
Triton X-100 (0.05-1.0% (wt/vol) final concentration),  or an equal volume of 
0.32 M sucrose. Activity in the presence of the nonionic detergent as compared 
with the control gave an indication  of the "latent"  thiamine  pyrophosphatase 
(22). 
For the protease inactivation studies, trypsin or acetylated trypsin was used. 
The activity of these proteases was determined  by their effect on a-N-benzoyl- 
L-arglnine ethyl ester. The trypsin preparation  contained  13,2OO U/rag while 
the  acetylated trypsin  preparation  contained  16,800 U/mg. The trypsin  and 
acetylated trypsin were used as 1 mg/mt solutions in 0.9% NaCI. The vesicle 
fractions (90-400  gl) were incubated  in the presence or absence of Triton X- 
100 (0.15  % wl/vol) with 0. l M Tris-HCl (pH 8.0) and trypsin or acetyltrypsin 
(ratio  of trypsin  to  protein,  1:40). Incubations  were  carried  out  at  room 
temperature,  30"C, and 37°C for 15,  20,  30, and 45  min. The reaction  was 
stopped by the addition  of soybean trypsin inhibitor  (10 times the amount of 
trypsin added), after which aliquots were taken for thiamine  pyrophosphatase 
assay. 
Orientation  of CST:  Latency and accessibility of [3sS]PAPS to CST 
were determined  by incubating  intact  vesicles with [asS]PAPS for 15, 30, and 
60 min in the absence of exogenous acceptor galactocerebroside. Another set 
of vesicles was treated similarly but with the addition  of Triton X-loo (0.2% 
wt/vol) to determine sulfation ofendngenous  substratc. "Latency ~ was assessed 
by treatment of the enzyme with Triton X-100 and determining the sulfation 
of exogenous substrate, as described for TPPas¢. The susceptibility of CST to 
protease digestion was also carried out as indicated for TPPase. 
Protein  Determination 
The proteins were assayed by the method of Lowry et al. (29) with bovine 
serum albumin as standard. FIGURE  1  Electron micrograph of Golgi-enriched vesicles obtained 
from 21-d-old  rat brain. The fractions were fixed, dehydrated, and 
then embedded as described in the text. x  35,000. 
RESULTS 
Characterization of the Vesicular Fraction 
In order to maintain the integrity of the vesicles,  the frac- 
tions were centrifuged onto a cushion of 1.6 M sucrose. The 
material that banded at the interface was examined by elec- 
tron microscopy. Fig.  l  shows a typical example of the frac- 
tions examined. Most of the organeUes  were smooth vesicles 
measuring 0.1-0.5 ~m in diameter with some profiles having 
a barbell shape. These structures are characteristic of  the Golgi 
apparatus in isolated fractions (30-32).  Very few mitochon- 
dria,  lysosomes, or polysomes were present and  no myelin 
was seen. Quantitation (by counting) showed that almost 80% 
of these observed structures were smooth vesicles.  Further- 
more, biochemical characterization (Table I) showed that the 
specific activity of thiamine pyrophosphatase in the isolated 
fraction was increased by about twofold over the activity in 
the homogenate. Similar results were obtained for cerebroside 
sulfotransferase. Both these enzymes are Golgi markers.  2 Thus 
the  vesicle preparation was enriched  in  Golgi markers and 
could be used to study the topography of TPPase and CST. 
Determination of Thiamine Pyrophosphatase in 
the Vesicles 
In order to  determine the  activity of TPPase,  a  suitable 
assay for quantitating the amount of phosphate was required. 
Of  the many assays available, the assay described by Heinonen 
and  Lahti (28) was the most suitable for our purposes. Ini- 
2  UDP-galactose:N-acetylglucosamine  galactosyltransfemse, another 
Golgi marker, was enriched twofold in our vesicle fraction, but the 
activity ( 1.5 nmol/h/mg protein) was too low for meaningful studies 
on orientation. 
tially, the blank values were high, due in part to interfering 
substances in the substrate thiamine pyrophosphate and to a 
lesser extent in the vesicle preparation itself.  Recrystallizing 
the thiamine pyrophosphate reduced the blank value by 30%. 
Turbidity of the supernatant solution after precipitating the 
proteins with tricbloracetic acid was decreased substantially 
by the addition of 100 el of 10% sodium dodecyl sulfate. The 
standard curve obtained was linear from 20 to 1,500 nmol of 
phosphorous with duplicate samples giving comparable val- 
ues. Known amounts of phosphorous could be added to our 
vesicle fractions, and recovered quantitatively. 
With use of this assay, TPPase was measured in the vesicle 
fraction as described under Materials and Methods. The re- 
action was linear with time for 15 min. All incubations were 
carded  out  for  5,  10,  15  and  20  rain,  but  for comparing 
activity in different preparations, the 10-min value was used. 
Comparison of activity of TPPase in vesicle fractions in the 
absence or presence of Triton  X-100,  showed that samples 
containing Triton X-100 had two- to threefold increases in 
specific activity of  the enzyme (Table II). According to Hirsch- 
berg (22),  such an increase in enzyme activity is due to the 
"latent" enzyme pool. This suggests that the isolated vesicles 
were not only intact, but also that they had the same orienta- 
tion as was found in the intact cell. 
In order to ensure that this "latent" pool of enzyme was 
thiamine pyrophosphatase and not nucleoside diphosphatase, 
we measured activity in the presence ofcysteine hydrochloride 
(10-50 mM), since nucleoside diphosphatase is inhibited by 
this  amino acid  (27).  In the  concentration  range  used,  no 
inhibition of the reaction was observed (Table II), indicating 
that we were indeed measuring thiamine pyrophosphatase. 
TABLE  I 
Thiamine Pyrophosphatase and Cerebroside Sulfotransferase 
Activities in the Vesicles Obtained from 2 l-d-old Rat Brain 
Thiamine  Cerebroside 
pyrophos-  sulfotrans- 
Preparation  phatase  ferase 
nmol/min/mg  dpm/min/mg 
protein  protein 
Homogenate  10  67 
Vesicles  20  370 
Solubilized  enzyme (1%  Triton  X-  50  1,500 
lOO} 
Enzyme activities were measured as described under Materials and Methods. 
The values given are the mean of three separate preparations. 
TABLE  II 
Activity  of Thiamine Pyrophosphatase 
Activity of 
Assay conditions  TPPase 
nmol/minlmg 
protein 
Homogenate 
Minus Triton X-tO0  10 
Plus Triton X-1OO (0.2%)  20 
Vesicle Fraction 
Minus Triton X-IOO  20 
Plus Triton X-IOO (0.2%)  50 
Plus Triton  X-IO0  (0.2%)  and  cysteine (10-50  52 
mM) 
Conditions are described  in the text. All experiments were performed on 
freshly prepared vesicles. 
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FIGURE  2  Golgi-enriched  vesicle  fractions  were  either  preincu- 
bated with trypsin, Triton X-100 only, or trypsin and Triton  X-100 
at 37*C for the time indicated. Control samples were vesicle frac- 
tions preincubated in buffer for the same times. At each time point 
aliquots were removed, soybean trypsin inhibitor was added, and 
thiamine pyrophosphatase was determined as described in the text. 
O, intact vesicles only; FI, intact vesicles +  trypsin; II, intact vesicles 
+  Triton; A, intact vesicles +  trypsin +  Triton. 
To confirm the topography of TPPase, the effect of pro- 
teases on these vesicles was determined (Fig.  2).  Incubation 
of intact vesicles with trypsin or acetyltrypsin  3 at room tem- 
perature, 30"C, and 37"C did not affect TPPase activity (Fig. 
2). To ensure that sufficient trypsin was present, the protein 
to trypsin ratio was varied from 5:1  to 40:1  and at none of 
these concentrations of  the protease was there any degradation 
of TPPase. However, if the vesicles were first made permeable 
with Triton X-100 and trypsin was then added, inactivation 
of luminal TPPase was observed (Fig.  2).  The optimal con- 
centration of Triton X-100 was in the range 0.15 % to 0.5 %. 
At 1.0% Triton X-100 there was spontaneous inactivation of 
TPPase, perhaps due to the release of lysosomal hydrolases. 
Even in intact vesicles made permeable with Triton X-100, 
the addition of trypsin did not lead to  100% inactivation. A 
maximum of 60%  inactivation was observed. Moreover, in 
attempts at solubilizing TPPase with  1% Triton X-100, only 
40%  of the total activity was measured in the  supernatant 
fraction, while the remainder of the activity was found in the 
pellet.  Our  data  indicate,  therefore,  that  both  soluble  and 
membrane-bound TPPase are inactivated by protease. 
Orientation  of CST 
As the vesicles were intact, sulfation of endogenous galac- 
tocerebroside was determined (Table III). The "active" sulfate 
donor PAPS, like other nucleotides, is unable to cross mem- 
branes. In the presence of [35S]PAPS, no sulfation of endoge- 
nous acceptor galactocerebroside was detected unless the ves- 
icles were first made permeable with Triton X-100 (Table III). 
Thus both the acceptor lipid galactocerebroside and the sul- 
fotransferase appear to be localized to the luminal side of the 
vesicles.  This agrees with the previous observation (18)  that 
UDP-galactose:ceramide galactosyltransferase and  CST  co- 
localize to the same Golgi fractions. 
Further support for this localization of CST was provided 
by  the  observation  that  Triton  X-100-solubilized  enzyme 
3  Trypsin and acetyltrypsin gave similar results and either could be 
used for these studies. 
showed a  15-fold  increase in the sulfation of exogenous gal- 
actocerebroside activity (Table II). Thus like TPPase, CST is 
also "latent." This observation taken in conjunction with the 
susceptibility of CST to proteases (trypsin or acetyltrypsin) 
only in the presence of Triton X-100 (Fig.  3),  suggests  that 
CST is located in the luminal aspect of the vesicles. Further- 
more,  trypsin  plus  Triton  X-100  resulted  in  only  partial 
inactivation of CST. 
To determine  whether  only the  solubilized  enzyme was 
inactivated, we examined the effect of various concentrations 
of Triton  X-100  on the  vesicles in  the presence of a  fixed 
amount of trypsin. We found that both soluble and mem- 
brane-bound forms of CST were inactivated in the presence 
of Triton  X-100 at concentrations from 0.05%-2%  (at the 
following  concentrations  of Triton  X-100--0.05,  0.1,  and 
0.2%--in the presence of trypsin, the inactivation of soluble 
CST was 35,  51, and 77%, while inactivation of membrane- 
bound CST was 65, 49, and 23%). 
Further evidence for the luminal localization of CST was 
provided by attaching galactosylsphingosine covalently to aga- 
rose beads and examining its sulfation by intact vesicles and 
by solubilized enzyme. With intact vesicles no sulfation was 
TABLE III 
Activity of Cerebroside Sulfotransferase in Golgi Vesicles 
Cerebroside 
sulfotransfer- 
Conditions  ase activity 
dpmlminlmg 
protein 
Vesicles +  PAPS  16 
Vesicles +  PAPS +  50 mM NaF  10 
Vesicles +  PAPS +  0.2% Triton X-100  100 
Vesicles +  PAPS +  50 mM NaF +  0.2% Triton  116 
X-lO0 
Vesicles were prepared as described under Materials and Methods. Mixtures 
contained the vesicles {about 100/~g of protein) in 0.32 M sucrose,  100 mM 
imidazole,  pH  6.2,  20  mM MgCl2, 4  mM  dithiothreitol, and  47  /~M  PAPS 
{specific  activity,  1  mCi/mmol)  in  100  /A.  NaF  and/or Triton  X-100  were 
included as indicated. The mixtures were incubated at 37°C for 7 rain, since 
with the nonextracted enzyme the reaction is linear  for about the first  10 
rain. Each value is the mean of three separate determinations. NaF was added 
to prevent degradation of PAPS by any phosphatases in the vesicle  prepara- 
tion. 
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FIGURE  3  Golgi-enriched vesicles were pretreated with trypsin at 
room temperature for the indicated periods of time, in the presence 
((2)---E))  or  absence  (G  O)  of  Triton  X-100.  Aliquots  were 
removed, soybean trypsin  inhibitor was  added,  and  cerebroside 
sulfotransferase was determined as described in the text. 
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solubilized enzyme, however, sulfation of psychosine beads 
was  observed  (650  dpm/min/mg  of protein);  with  boiled 
enzyme, sulfation was negligible. 
DISCUSSION 
Knowledge of the location of sulfatide in myelin and plasma 
membranes would aid immeasurably in specifying the func- 
tions of this complex sulfolipid. In the absence of a suitable 
marker for sulfatide in the central nervous system, we took 
advantage of the fact that the synthetic enzyme CST is located 
in the Golgi-rich fraction in the CNS (l 8, 19). Previous studies 
had shown that by analyzing Golgi vesicles for the location of 
the enzymes involved in the formation of complex carbohy- 
drates, it was possible to predict the orientation of the glyco- 
protein products in the plasma membrane (21-23, 33). This 
orientation was subsequently confirmed by other methods. 
To apply these techniques in our studies it was necessary to 
prepare intact microsomal vesicles enriched in Golgi markers, 
such as thiamine pyrophosphatase, and in CST (Table I). The 
orientation of CST in these vesicles should allow predictions 
to be made about the location of the sulfatide product within 
these vesicles,  provided that the isolated vesicles were intact 
and impermeable to hydrolytic enzymes and that the topog- 
raphy of the membrane was the same as that in the intact 
cell. 
Cytochemical studies have shown that the reaction product 
of thiamine pyrophosphatase is deposited on the luminal side 
of the Golgi membranes in vivo (34).  Based on two lines of 
evidence, we found the same orientation of thiamine pyro- 
phosphatase activity in  our preparation.  First,  activity was 
increased  about  threefold  in  the  presence  of the  nonionic 
detergent Triton X-100 (Table II). This activation has been 
attributed to the fact that much of this enzyme is normally 
"latent" within the luminal aspect of the Golgi apparatus and 
becomes available upon treatment with Triton  X-100 (22). 
Second, thiamine pyrophosphatase is resistant to inactivation 
by external proteases. However, in the presence of Triton X- 
100, which renders the vesicles permeable to the proteases, 
the  pyrophosphatase is  inactivated  by trypsin  (Fig.  2).  As 
expected, this inactivation is not complete, since a portion of 
the enzyme remains inaccessible to trypsin. These observa- 
tions led us to conclude that our vesicles were right-side-out 
and that they were intact. 
With the intact right-side-out vesicle preparation we used 
three approaches to investigate the orientation of CST. First, 
we examined the sulfation of endogenous galactocerebroside 
by  3'-phosphoadenosine  5'-phospho[35S]sulfate  in  the  ab- 
sence and presence of Triton X-100 (Table III). We found no 
sulfation of endogenous galactocerebroside unless the vesicles 
were incubated with PAPS and Triton X-100.  Under these 
conditions PAPS could traverse the permeabilized membrane 
and sulfatide synthesis was observed (Table III). It is unlikely 
that the labeled exogenous PAPS will be diluted by endoge- 
nous substrate, as the PAPS synthetic enzymes are probably 
located in the cytoplasm, in common with other nucleotide 
synthetases (35).  Thus, the PAPS so formed, because of its 
structure, would be unable to cross membranes in the absence 
of a specific carrier, such as has been found for sugar nucleo- 
tides (36,  37).  In addition, we showed that CST activity was 
latent, that the enzyme was resistant to the action of trypsin 
unless the  vesicles were treated with Triton X-100 (Fig.  3) 
and, finally, that agarose-linked galactosylsphingosine was not 
sulfated by intact vesicles.  From these results it seems clear 
that CST, like thiamine pyrophosphatase, is located on the 
luminal side of the Golgi apparatus, suggesting,  in turn, that 
sulfatide has a similar location and that it will be located in 
the outer half (intraperiod line) of the myelin bilayer. 
How lipids elaborated in the Golgi complex are sorted and 
then targeted to specific membranes is not known (38).  For 
example, how are the lipid constituents destined for myelin 
transported to this membrane and maintained in the appro- 
priate  conformation? Like  other  membranes, the  lipids  in 
myelin are arranged asymmetrically in the lipid bilayer and 
appear to be localized in specific domains (39). In this context, 
it is of interest that galactocerebroside, the precursor of sul- 
fatide, appears to be located on the outer half of the myelin 
membrane.  For  instance,  the  C-6  hydroxyl  group  of the 
galactose moiety is accessible to the enzyme galactose oxidase 
(40);  furthermore, Saida et al. (41) showed that when anti- 
galactocerebroside antibody was injected into peripheral nerve 
or into the dorsal column of the spinal cord, demyelination 
was induced. We have recently confirmed this observation in 
both central and peripheral nervous system of rats by using a 
monoclonal antibody to galactocerebroside. As the antibody 
cannot penetrate the lipid bilayer, interaction with galactocer- 
ebroside would not occur unless this lipid were located in the 
outer half of the lipid bilayer. This location of the precursor 
galactocerebroside lends credence to the notion that sulfatide 
is also found in the outer layer. Moreover, Abrahamsson and 
co-workers (42)  have shown that the sugar moiety of galac- 
tocerebroside  is arranged  parallel to  the  membrane rather 
than being oriented perpendicular to the lipid bilayer. Presum- 
ably sulfatide would show a similar orientation. In biological 
membranes, sulfatide  is  hydrated,  so  that  it  is  unlikely  to 
display "flip-flop" movement; as  shown  by Kornberg and 
McConnell  (15),  complex  lipids  in  general  undergo  such 
movement only very slowly.  Because of this arrangement in 
the lipid bilayer, it is likely that the asymmetrical distribution 
of sulfatide in the myelin membrane is maintained. 
To  our  knowledge  this  is  the  first  investigation  of the 
orientation of an enzyme involved in the synthesis of  complex 
glycolipids in intact vesicles enriched in Golgi markers. The 
presence of CST in the luminal aspect of such vesicles suggests 
a mechanism whereby sulfatide is asymmetrically assembled 
in the outer layer of myelin. We plan to establish this orienta- 
tion  unequivocally by use  of immunocytochemical studies 
with antibodies to the enzyme and to sulfatide. 
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